MEI Pharma has an EPS of $-4.78. In 2022, the company made an earnings per share (EPS) of $-9.99. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$4.78 | -52.15% |
2022 | -$9.99 | -16.75% |
2021 | -$12.00 | 15.38% |
2020 | -$10.40 | - |